Previous close | 13.72 |
Open | 13.42 |
Bid | 13.90 |
Ask | 15.25 |
Strike | 165.00 |
Expiry date | 2025-03-21 |
Day's range | 13.41 - 14.02 |
Contract range | N/A |
Volume | |
Open interest | 286 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.